Duan Z - Search Results

1

Multidrug resistant osteosarcoma cell lines exhibit deficiency of GADD45alpha expression.

Yang C, Yang S, Wood KB, Hornicek FJ, Schwab JH, Fondren G, Mankin H, Duan Z. Yang C, et al. Among authors: duan z. Apoptosis. 2009 Jan;14(1):124-33. doi: 10.1007/s10495-008-0282-x. Apoptosis. 2009. PMID: 19052873

2

Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.

Lamendola DE, Duan Z, Yusuf RZ, Seiden MV. Lamendola DE, et al. Among authors: duan z. Cancer Res. 2003 May 1;63(9):2200-5. Cancer Res. 2003. PMID: 12727840

3

Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.

Duan Z, Duan Y, Lamendola DE, Yusuf RZ, Naeem R, Penson RT, Seiden MV. Duan Z, et al. Among authors: duan y. Clin Cancer Res. 2003 Jul;9(7):2778-85. Clin Cancer Res. 2003. PMID: 12855658

4

MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines.

Duan Z, Brakora KA, Seiden MV. Duan Z, et al. Gene. 2004 Sep 29;340(1):53-9. doi: 10.1016/j.gene.2004.06.013. Gene. 2004. PMID: 15556294

5

Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.

Duan Z, Lamendola DE, Duan Y, Yusuf RZ, Seiden MV. Duan Z, et al. Among authors: duan y. Cancer Chemother Pharmacol. 2005 Mar;55(3):277-85. doi: 10.1007/s00280-004-0878-y. Epub 2004 Nov 24. Cancer Chemother Pharmacol. 2005. PMID: 15565326

6

GBP1 overexpression is associated with a paclitaxel resistance phenotype.

Duan Z, Foster R, Brakora KA, Yusuf RZ, Seiden MV. Duan Z, et al. Cancer Chemother Pharmacol. 2006 Jan;57(1):25-33. doi: 10.1007/s00280-005-0026-3. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16028104

7

Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer.

Duan Z, Foster R, Bell DA, Mahoney J, Wolak K, Vaidya A, Hampel C, Lee H, Seiden MV. Duan Z, et al. Clin Cancer Res. 2006 Sep 1;12(17):5055-63. doi: 10.1158/1078-0432.CCR-06-0861. Clin Cancer Res. 2006. PMID: 16951221

8

Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer.

van Vlerken LE, Duan Z, Seiden MV, Amiji MM. van Vlerken LE, et al. Among authors: duan z. Cancer Res. 2007 May 15;67(10):4843-50. doi: 10.1158/0008-5472.CAN-06-1648. Cancer Res. 2007. PMID: 17510414

9

Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer.

Devalapally H, Duan Z, Seiden MV, Amiji MM. Devalapally H, et al. Among authors: duan z. Int J Cancer. 2007 Oct 15;121(8):1830-8. doi: 10.1002/ijc.22886. Int J Cancer. 2007. PMID: 17557285

10

CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.

Duan Z, Ames RY, Ryan M, Hornicek FJ, Mankin H, Seiden MV. Duan Z, et al. Cancer Chemother Pharmacol. 2009 Mar;63(4):681-9. doi: 10.1007/s00280-008-0785-8. Epub 2008 Jun 28. Cancer Chemother Pharmacol. 2009. PMID: 18587580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,015 results

Search Page

Filters